Herbal dietary supplements (HDS) used for dyslipidemia represent a category of concern in Italy for suspected adverse reactions (ARs). However, we cannot estimate their safety, as we do not know their commercial profile. Sales data of HDS, and particularly, those used for dyslipidemia, were monitored for 2 years in two pharmacies of Rome. Meanwhile, spontaneous reports of suspected ARs potentially related to dyslipidemia supplements were collected by the Italian Phytovigilance System. The 50% of the total dietary supplements are herbal-derived; the 9% of HDS are recommended for dyslipidemia. From our data, 113 different brands have claims for improving lipids profile and 91% of them are multiingredient preparations. Fifteen spontaneous reports of suspected ARs concerned HDS used, for dyslipidemia. The most frequent ARs were joint, abdominal, and muscles pain; vomiting; erythema and hematological disorders; nausea; and rhabdomyolysis. Our findings point out the limited compliance of commercial dyslipidemia-HDS and scientific research about their intrinsic safety. A wide range of ingredients could not support the risk/benefit profile of the supplement. The variable compositions of HDS do not assure the safety, as they do not support the reproducibility of their pharmacological activities. This study could contribute to optimize consumer guidance about what they purchase and consume.

A descriptive study of commercial herbal dietary supplements used for dyslipidemia—Sales data and suspected adverse reactions / Allkanjari, Olta; Menniti-Ippolito, Francesca; Ippoliti, Ilaria; DI GIACOMO, Silvia; Piccioni, Tito; Vitalone, Annabella. - In: PHYTOTHERAPY RESEARCH. - ISSN 1099-1573. - (2022), pp. 1-22. [https://doi.org/10.1002/ptr.7473]

A descriptive study of commercial herbal dietary supplements used for dyslipidemia—Sales data and suspected adverse reactions

Olta Allkanjari
Primo
;
Silvia Di Giacomo;Annabella Vitalone
Ultimo
2022

Abstract

Herbal dietary supplements (HDS) used for dyslipidemia represent a category of concern in Italy for suspected adverse reactions (ARs). However, we cannot estimate their safety, as we do not know their commercial profile. Sales data of HDS, and particularly, those used for dyslipidemia, were monitored for 2 years in two pharmacies of Rome. Meanwhile, spontaneous reports of suspected ARs potentially related to dyslipidemia supplements were collected by the Italian Phytovigilance System. The 50% of the total dietary supplements are herbal-derived; the 9% of HDS are recommended for dyslipidemia. From our data, 113 different brands have claims for improving lipids profile and 91% of them are multiingredient preparations. Fifteen spontaneous reports of suspected ARs concerned HDS used, for dyslipidemia. The most frequent ARs were joint, abdominal, and muscles pain; vomiting; erythema and hematological disorders; nausea; and rhabdomyolysis. Our findings point out the limited compliance of commercial dyslipidemia-HDS and scientific research about their intrinsic safety. A wide range of ingredients could not support the risk/benefit profile of the supplement. The variable compositions of HDS do not assure the safety, as they do not support the reproducibility of their pharmacological activities. This study could contribute to optimize consumer guidance about what they purchase and consume.
2022
dyslipidemia, herbal dietary supplement, monacolin K, red yeast rice, sales data, suspected adverse reactions
01 Pubblicazione su rivista::01a Articolo in rivista
A descriptive study of commercial herbal dietary supplements used for dyslipidemia—Sales data and suspected adverse reactions / Allkanjari, Olta; Menniti-Ippolito, Francesca; Ippoliti, Ilaria; DI GIACOMO, Silvia; Piccioni, Tito; Vitalone, Annabella. - In: PHYTOTHERAPY RESEARCH. - ISSN 1099-1573. - (2022), pp. 1-22. [https://doi.org/10.1002/ptr.7473]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1631722
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact